Abstract
5-aminosalicylic acid (5-ASA or mesalazine) is widely used for treatment of inflammatory bowel disease and considered to be cancer preventive. Still, the molecular mechanisms explaining its properties remain largely unknown, partially due to the lack of instrumentarium needed to identify its array of molecular targets. Modern OMICs-based technologies utilized in this study may serve as a powerful and unbiased tool to search for such targets. Here we demonstrate that 5-ASA alters β-catenin immunocomplex formation by changing complex binding of seven proteins including translation initiation factors eIF4b. OMICs-based cross-testing by reverse in-gel chemogenomics (utilizing 5-ASAs fluorescent properties), in-silico docking and surface plasmon resonance experiments identified binding of 5-ASA to eIF4es capbinding pocket, a key regulatory site for protein synthesis. In-vitro translation experiments with rabbit reticulocytes confirmed a dose-dependent inhibition of protein syntheses by 5-ASA. By using two unbiased and independent OMICs-based experimental approaches two members of the cellular translation machinery, eIF4b and IF4e, were identified as targets of 5-ASA. Inhibition of protein syntheses is a previously unrecognized property of 5-ASA that may add to its antiinflammatory and anti-neoplastic activities.
Keywords: 5-ASA, chemogenomics, 2D-DIGE, IBD, mesalazine, OMICs, ß-catenin, initiation factors, in-silico docking, surface plasmon resonance, in-gel chemogenomics, antiinflammatory, anti-neoplastic activities
Medicinal Chemistry
Title: Interaction of Mesalasine (5-ASA) with Translational Initiation Factors eIF4 Partially Explains 5-ASA Anti-Inflammatory and Anti-Neoplastic Activities
Volume: 7 Issue: 2
Author(s): Alex Lyakhovich, Anna Michlmayr, Anastasia Bakulina, Christopher Gerner, Rudolf Oehler and Christoph Gasche
Affiliation:
Keywords: 5-ASA, chemogenomics, 2D-DIGE, IBD, mesalazine, OMICs, ß-catenin, initiation factors, in-silico docking, surface plasmon resonance, in-gel chemogenomics, antiinflammatory, anti-neoplastic activities
Abstract: 5-aminosalicylic acid (5-ASA or mesalazine) is widely used for treatment of inflammatory bowel disease and considered to be cancer preventive. Still, the molecular mechanisms explaining its properties remain largely unknown, partially due to the lack of instrumentarium needed to identify its array of molecular targets. Modern OMICs-based technologies utilized in this study may serve as a powerful and unbiased tool to search for such targets. Here we demonstrate that 5-ASA alters β-catenin immunocomplex formation by changing complex binding of seven proteins including translation initiation factors eIF4b. OMICs-based cross-testing by reverse in-gel chemogenomics (utilizing 5-ASAs fluorescent properties), in-silico docking and surface plasmon resonance experiments identified binding of 5-ASA to eIF4es capbinding pocket, a key regulatory site for protein synthesis. In-vitro translation experiments with rabbit reticulocytes confirmed a dose-dependent inhibition of protein syntheses by 5-ASA. By using two unbiased and independent OMICs-based experimental approaches two members of the cellular translation machinery, eIF4b and IF4e, were identified as targets of 5-ASA. Inhibition of protein syntheses is a previously unrecognized property of 5-ASA that may add to its antiinflammatory and anti-neoplastic activities.
Export Options
About this article
Cite this article as:
Lyakhovich Alex, Michlmayr Anna, Bakulina Anastasia, Gerner Christopher, Oehler Rudolf and Gasche Christoph, Interaction of Mesalasine (5-ASA) with Translational Initiation Factors eIF4 Partially Explains 5-ASA Anti-Inflammatory and Anti-Neoplastic Activities, Medicinal Chemistry 2011; 7 (2) . https://dx.doi.org/10.2174/157340611794859325
DOI https://dx.doi.org/10.2174/157340611794859325 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Functional Foods: Salient Features and Clinical Applications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Current Pharmaceutical Design Research Advances in Neuroblastoma Immunotherapy
Current Pediatric Reviews The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology An Update on Developments in Female Hormonal Contraception
Current Women`s Health Reviews A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
Current Cancer Therapy Reviews The Pro-Survival Function of Akt Kinase can be Overridden or Altered to Contribute to Induction of Apoptosis
Current Cancer Drug Targets Distinct DNA Metabolism and Anti-proliferative Effects of Goat Urine Metabolites: An Explanation for Xeno-tumor Heterogeneity
Current Chemical Biology Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size
Current Drug Delivery Preparation and Characterization of Nanoemulsome Entrapped in Enteric Coated Hydrogel Beads for the Controlled Delivery of Capsaicin to the Colon
Current Drug Therapy Chronic Inflammation and Colorectal Cancer: The Role of Vascular Endothelial Growth Factor
Current Pharmaceutical Design Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science Chemical Characterization and Antioxidant Potential of <i>Athroisma proteiformis</i> Essential Oil
The Natural Products Journal Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
Current Drug Targets New 1-phthalazinone Scaffold based Compounds: Design, Synthesis, Cytotoxicity and Protein Kinase Inhibition Activity
Mini-Reviews in Medicinal Chemistry Review of Current Chemoinformatic Tools for Modeling Important Aspects of CYPsmediated Drug Metabolism. Integrating Metabolism Data with Other Biological Profiles to Enhance Drug Discovery
Current Drug Metabolism